{Reference Type}: Case Reports
{Title}: Intravitreal Bevacizumab in Management of Persistent Secondary Macular Hole with Epiretinal Proliferation.
{Author}: Zangmo U;Jayanna S;Shanmugam MP;
{Journal}: Nepal J Ophthalmol
{Volume}: 15
{Issue}: 30
{Year}: 2023 Jul
暂无{DOI}: 10.3126/nepjoph.v15i2.55033
{Abstract}: <B>BACKGROUND: </B>Aetiology for non-closure of full-thickness macular hole (FTMH) becomes crucial in determining the method of effective mode of intervention. Association of epiretinal proliferation (ERP) along with full-thickness macular hole (FTMH) have shown poorer anatomic and visual outcomes after surgical intervention. Various surgical techniques have been described in literature for treatment of persistent MH.<BR><B>METHODS: </B>We report a A 60-year-old female patient with FTMH secondary to branched retinal vein occlusion (BRVO) initially associated with ERP.<BR><B>METHODS: </B>She was successfully managed by treating with combination of intravitreal injection of off label bevacizumab (Avastin) (1.25 mg/0.05 ml) and pure gas of SF6 (1 cc) under topical anaesthesia after an initial surgical intervention.<BR><B>CONCLUSIONS: </B>Presence of ERP in retinal vein occlusion cases needs closer and frequent follow up. IVB can be used as an adjunct in treating secondary MH.